CA
NZ
UK
AU
IND
US
A busy summer of clinical and financing announcements has kept 60 Degrees Pharmaceuticals, Inc (NASDAQ:SXTP) in the conversation among small-cap biotech watchers, even as the shares trade below a dollar. The Washington, D.C.-area infectious-disease specialist is best known for antiparasitic work, and it heads …
Once a well-funded cancer-drug developer, Syros Pharmaceuticals has faded from public markets after a pivotal trial setback. Syros Pharmaceuticals (OTC: SYRS) now changes hands for a fraction of a cent, a shadow of the Nasdaq-listed biotech that once carried a nine-figure valuation. The quiet …
Few small-capMedTechnames have had a more eventful 2026 than TELA Bio, Inc (NASDAQ:TELA), a commercial-stage soft-tissue reconstruction company that spent the summer overhauling itsLeadershipand attacking its cost base. Trading onNasdaqunder the ticker TELA, the shares slipped below a dollar, a level that heightens bothVolatilityand …
The ticker TLOG still generates a sub-penny quote, which can create the impression of a company biding its time before a comeback. The reality is starkly different. TetraLogic Pharmaceuticals Corporation (OTC:TLOG) ceased to be a normal, reporting public company almost a decade ago, havingDelistedfrom …
Statera Biopharma, Inc. (OTC:STAB) entered the public markets with an ambitious immunotherapy pipeline and a portfolio of drug candidates aimed at autoimmune disease, radiation injury and cancer. Today the reality is starker: its most valuable asset has been licensed away to another company.
● STERIS has quietly become one of the most dependable operators in healthcare infrastructure, and in September 2026 the stock sits near $215 with a marketCapitalizationnorth of $20 billion on the New York Stock Exchange.
Priced at a fraction of a cent, Stemtech Corporation (OTC:STEK) is about as far down the market-cap ladder as a listed company can go. The wellness and nutrition marketer, which sells plant-based stem-cell support supplements, trades on the OTC Pink tier at roughly $0.0001 …
● Neuronetics offered a rare upbeat signal on an otherwise cautious tape, with STIM shares ticking higher as the maker of NeuroStar transcranial magnetic stimulation therapy pushes toward profitability.
● Headquartered in Piombino Dese near Padua, Stevanato traces its roots to a glassmakingBusinessfounded in 1949 and today spans two segments: Biopharmaceutical and Diagnostic Solutions, which supplies drug-containment and delivery products, and Engineering, which builds assembly and inspection machinery.
The company behind the HydraFacial treatment has spent the past two years working to stabilize aBusinessthat grew fast and then stumbled. Now trading as SkinHealth Systems Inc. (NASDAQ: SKIN) after rebranding from The Beauty Health Company in April 2026, the Nasdaq-listed aesthetics group is …
Please wait processing your request...